Morocco Opens $8.5M Syringe Factory, Creating 70 Jobs

Morocco is now home to a state-of-the-art medical manufacturing facility that will produce nearly half a billion syringes each year. IM Medicare inaugurated its new $8.5 million factory in Sidi Bou Othmane, marking a major step forward for healthcare independence across the continent.

The facility will create 70 direct jobs in the Marrakech-Safi region while producing 450 million hypodermic and vaccination syringes annually. Industry and Trade Minister Ryad Mezzour joined local officials to celebrate the opening at the Sidi Bou Othmane industrial park.

What makes this factory special is its timing and credentials. IM Medicare was founded during the COVID-19 pandemic when the world faced critical medical supply shortages. In 2025, the company earned World Health Organization certification for its self-locking syringe, joining the ranks of elite global manufacturers.

"This project illustrates the capacity of Moroccan companies to innovate, produce with excellence, and establish themselves as reliable and recognized suppliers on the global vaccination device market," Mezzour said at the ceremony. The minister emphasized how the facility strengthens Morocco's health sovereignty while building the country's "Made in Morocco" reputation.

CEO Mohamed Idrissi Kaitouni describes the factory as a major milestone that meets international quality and safety standards. The WHO certification opens doors to international tenders, particularly those supporting vaccination programs across Africa.

The Ripple Effect

This factory represents more than just local job creation. Morocco's medical device sector has shown remarkable growth over 25 years, now supporting 1,378 jobs and generating $90 million in annual revenue with investments reaching $37.6 million.

The facility addresses a critical need for medical sovereignty while positioning Morocco as a healthcare hub for African markets. By producing competitively priced, high-quality syringes locally, Morocco reduces dependence on imports while supporting neighboring countries' healthcare needs.

The project reflects Morocco's broader strategy to develop high-value industries that create qualified jobs and strengthen regional economic development. As vaccination programs expand across Africa, having a certified local manufacturer becomes increasingly vital for healthcare accessibility.

Morocco's newest factory proves that strategic investment in healthcare manufacturing can deliver jobs, sovereignty, and hope for better health outcomes across an entire continent.